European Medicines Agency Accepts Extension of Marketing Authorisation Application for Review of Celltrion's Remsima SC, the Subcutaneous Version of Remsima

Celltrion and Teva Announce FDA Approval of Truxima, a Biosimilar to Rituxan, for Three Non-Hodgkin's Lymphoma Indications

Elekta announces receipt of FDA 510(k) clearance in US by Elekta Unity

Prometic Life Sciences Inc to proceed with lead anti-fibrotic drug candidate PBI-4050 for Alström syndrome

Subtle Medical passes the US FDA 510(k) clearance and CE Mark approval for SubtlePET for medical imaging

Children's Hospital announces European Commission's first-of-its-kind gene therapy approval for blindness

AbbVie halts admission under the TAHOE Phase 3 study of Rovalpituzumab Tesirine for advanced small-cell lung cancer

Medicenna awarded USD1.2m non-dilutive grant from CPRIT

European Commission Approves Merck's Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and Pifeltro (doravirine), an NNRTI, Both for the Treatment of HIV-1 in Ap

Novartis receives US FDA priority review for Zolgensma

Momenta Pharmaceuticals revises US M923 regulatory strategy

IDEAYA Biosciences names Bao Truong as VP of Regulatory Affairs

Innovent to launch clinical trials of Anti-OX40 Monoclonal Antibody IBI101 upon US FDA approval

Tiziana Initiates Phase 1 Clinical Trial with Nasal Administration of Foralumab, a Fully Human Anti-Cluster Definition 3 Monoclonal Antibody (anti-CD3 mAb), in Healthy Volunteers

US Bioservices Selected by Bayer and Its Collaboration Partner Loxo Oncology, Inc. to Dispense Vitrakvi